Tis the season for gathering inside and being surrounded by loved ones — which, unfortunately, makes it much easier to spread and catch COVID-19, RSV, the flu and norovirus. And it’s not just cuddling ...
Data since the early 1900s indicate that influenza might increase the risk for cardiovascular complications. Today, we know ...
As health service chiefs warn of a ‘tidal wave’ of viral infections, Sean O’Grady looks at the causes and implications of the crisis facing our hospitals ...
The FDA has placed a hold on all clinical studies of vaccines for respiratory syncytial virus in infants due to safety concerns following a trial involving two mRNA-based vaccine candidates from ...
Early results from Blue Lake trial found the vaccine to be safe, tolerated and able to cut the chance of contracting the infection.
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...
CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...
The burden of respiratory syncytial virus in young children continues to be high in the United States, according to study findings.
A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...
Bengaluru doctors are warning residents about a surge in respiratory and gastrointestinal infections attributed to ...
Finding a cure for colds and the flu is tricky to say the least, but new science may help you prevent them or at least ...
COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback